Charles Patti is one of the Co-Founders of Eleusis, a luxury psychedelic immersion center located on the Caribbean isle of St. Vincent and The Grenadines.

We learn about the extended state DMT protocol which is actively being administered to guests at the beachfront luxury clinic thanks to a government license, as well as the broader vision guiding the work at Eleusis.

This episode is brought to you by Full Canopy Genetics and by Mycogenius

Hosted on Acast. See acast.com/privacy for more information.

Travis Tyler Fluck was instrumental in laying the groundwork for the passage of decriminalization of entheogenic fungi in Denver, and he's been deeply involved in the community there for the arc of Prop 122 and the Natural Medicine Health Act. Today he returns to the Mycopreneur Podcast to share about his upcoming appearance at the Aspen Psychedelic Symposium where he'll be gifting 400 therapeutic level doses of psilocybin mushrooms away to attendees for free. The total cost of inputs and production of the 400 doses costs Travis was able to produce each dose for .43 cents each, totaling less than one person undergoing one licensed and legal psilocybin mushroom therapy session under the state-regulated framework.

This episode is brought to you by Full Canopy Genetics

This episode is also brought to you by Mycogenius

Hosted on Acast. See acast.com/privacy for more information.

Seth Colchester is the Founder of Mycogenius, a Netherlands-based manufacturer of premium functional mushroom extracts that are third-party tested and fully traceable. He is also the founder of Functionalmushrooms.eu, a wholesale provider of premium functional mushroom extracts and white labeling service for international brands.

Seth joins me today to discuss the mushroom industry in the EU in regards to culture, regulations, and market opportunity as it currently stands.

Please rate and review this podcast on whichever platform you're listening you're listening ( :

Hosted on Acast. See acast.com/privacy for more information.

Shelby Hartman is a journalist best known as the Co-Founder of the pre-eminent psychedelic media platform DoubleBlind.

Today she returns to the Mycopreneur Podcast to discuss the evolution of the psychedelic media landscape as well as shifting public perceptions of psychedelics over the last decade since she helped launch one of the first prominent independent media platforms covering the subject.

We also discuss the new book she co-authored with her DoubleBlind Co-Founder Madison Margolin titled "The DoubleBlind Guide to Psychedelics: A Roadmap to Tripping, Microdosing, and Beyond"

This episode is brought to you by Mycogenius, third-party tested and fully traceable premium functional mushroom extracts

Hosted on Acast. See acast.com/privacy for more information.

Lee Carroll returns to the Mycopreneur Podcast to discuss his novel research into Ergothioneine as a support framework for psychedelic therapy and neuroplasticity. Lee unpacks complex concepts like the BDNF pathway, cellular phosphorylation, and the transformative power of hydrogen sulfide at the cellular level in digestible phrasing for non-clinicians.

This episode is brought to you by Real Mushrooms

Please rate and review this episode on whichever platform you're listening

Hosted on Acast. See acast.com/privacy for more information.

Adam Miezio is a journalist and content marketer in the psychedelic space who serves as the Guild Master of the Psychedelic Writers Guild and the writer behind The Divine Influx on Substack among other roles. Today we discuss the state of psychedelic journalism and dive down the rabbit hole of the connection between psychedelics and the Epstein Files in addition to other interesting topics at the intersection of psychedelics and largely untold stories.

Please rate and review this episode wherever you're listening

Hosted on Acast. See acast.com/privacy for more information.

Robert Gallery is an NFL veteran who is the Founder of Athletes For Care, an organization supporting research, advocacy, and real solutions for athlete mental health. He joins me today to discuss his transformation from a retired NFL star with severe mental health issues to a pioneer in the psychedelic therapy advocacy and research space for athletes. This episode was recorded several weeks prior to the recent Executive Order signed by President Trump which fast-tracks psychedelic research for 'Breakthrough Therapies' including Ibogaine.

Please rate and review this episode wherever you're listening

Hosted on Acast. See acast.com/privacy for more information.

Melanie Tremblay is the Chief Operating Officer of Real Mushrooms, one of the most reputable and influential mushroom companies in North America. She draws from her background in the beauty and cosmetics industry to discuss advertising trends and exaggerated claims as well as flat out misinformation in the functional mushroom industry today as it continues to grow into a major category. 

Please rate and review this episode wherever you're listening 

Hosted on Acast. See acast.com/privacy for more information.

Full Canopy Genetics is a prize-winning mushroom genetics and mycology research supplies vendor based in Denver, Colorado. Founders Santi & Spoon join me today to discuss their path into the mushroom genetics space, the spores and cultures they're working with, the international mushroom scene, and how to breed a truly viable and high yielding mushroom strain.

Hosted on Acast. See acast.com/privacy for more information.

Jeffrey Miller is the CEO of HoneyProjects, a visionary force reshaping the legal cannabis market in New Jersey. He's also a graduate of the Vital Psychedelic Training Program and has earned a wealth of knowledge from over a decade of experience in the cannabis industry that can be applied to the emergent psychedelic industry. We discuss each of these scenarios in depth today on the podcast.

Thank you to Full Canopy Genetics for supporting this episode of Mycopreneur Podcast

Please rate and review this episode on Spotify, Apple Podcasts, or wherever else you're listening

Hosted on Acast. See acast.com/privacy for more information.